TY - JOUR A1 - López López, Rafael T1 - A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC) Y1 - 2015 SN - 0732-183X UR - http://hdl.handle.net/20.500.11940/7939 LA - eng ER -